Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Beyond Ventures' first investment, Prenetics, becomes first Hong Kong unicorn to go public 2021-09-16 15:31
SuperTrans Medical supported by U.S. National Institutes of Health (NIH) in developing its lead antibiotic against urgent threat drug resistant bacteria 2021-09-16 08:45
Eleva Reaches Industrial Production Scale and Prepares for Clinical Development of Factor H 2021-09-14 10:30
RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval 2021-09-13 19:00
FUJIFILM Diosynth Biotechnologies and NeuExcell Therapeutics enter manufacturing agreement to rapidly advance NXL-001, a potential neuro-regeneration gene therapy to treat ischemic cortical stroke 2021-09-13 18:00
Hummingbird Bioscience Announces US FDA Clearance of IND for First-in-Human Phase 1 Trial of HMBD-002 in Patients with Advanced Solid Tumors 2021-09-13 17:00
Everest Medicines Enters into Comprehensive Agreements with Providence Therapeutics to Advance mRNA Vaccines and Therapies, including COVID-19 Vaccines, in Asia Emerging Markets 2021-09-13 17:00
Cytiva triples single-use consumables capacity in China 2021-09-10 16:33
Clover Biopharmaceuticals Receives Pharmaceutical Manufacturing Permit from Zhejiang Medical Products Administration to Produce COVID-19 Vaccine 2021-09-09 19:51
ABILITY Diabetes Global enrolls thousandth patient: A Cardinal Milestone Achieved 2021-09-09 19:26
PAQ Therapeutics Announces Collaboration with Insilico Medicine to Develop Novel Therapies through Autophagy-Dependent Degradation 2021-09-09 19:20
China's Northernmost Free Trade Zone Sees Wider Reform and Opening-up 2021-09-09 18:12
HaemaLogiX raises $10 million to advance multiple myeloma treatments 2021-09-09 05:00
Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza 2021-09-08 20:30
Gannex Announces Positive Topline Results from the U.S. Phase I Trial of Drug-Drug Interactions in Healthy Subjects and Pharmacokinetics in Patients with NAFLD for Its THRβ Agonist ASC41 2021-09-08 08:30
Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China 2021-09-08 08:00
Further Study in humans shows that the DTH response, the basis for CoviDTH, is highly durable and persists for at least one year after COVID-19 exposure or vaccine administration 2021-09-07 20:00
RedHill Biopharma's Opaganib Demonstrates Significant Decrease of Kidney Fibrosis 2021-09-07 19:00
RedHill Biopharma Presents Three New Analyses of Movantik Data at PAINWeek 2021 2021-09-07 18:00
Jubilant Biosys Limited announces the appointment of Mr. Giuliano Perfetti as Chief Executive Officer 2021-09-07 16:11
1 103 104 105 106 107 212